Top Markets
#1 Seeker Seeker +15.40%
#2 Official Trump Official Trump +12.94%
#3 DeFi Kingdoms DeFi Kingdoms +10.56%
#4 Ethena Staked ENA Ethena Staked ENA +9.25%
#5 EXOD EXOD +9.04%
#6 Wrapped Aave Ethereum WETH Wrapped Aave Ethereum WETH +8.10%
#7 peaq peaq +7.28%
#8 TDCCP TDCCP +5.86%
#9 Melania Meme Melania Meme +5.55%
#10 Stacks Stacks +5.26%
Coin of the day
Seeker Seeker
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Taysha Gene Therapies, Inc. Taysha Gene Therapies, Inc.

Taysha Gene Therapies, Inc.

TSHA
Rang in aandelen #6652
Taysha Gene Therapies, Inc. is a biotech firm specializing in the creation and... Taysha Gene Therapies, Inc. is a biotech firm specializing in the creation and market introduction of gene therapies that utilize adeno-associated virus (AAV) vectors. Its core mission is to tackle inherited diseases affecting the central nervous system (CNS). The company's development pipeline features several key programs: TSHA-120 is aimed at giant axonal neuropathy; TSHA-102 is in development for Rett syndrome; TSHA-121 and TSHA-118 are both being advanced for CLN1 disease; TSHA-105 addresses SLC13A5 Deficiency; and TSHA-101 targets GM2 gangliosidosis. Furthermore, Taysha has forged a strategic alliance with The University of Texas Southwestern Medical Center to jointly advance and bring to market innovative gene therapy solutions. Founded in 2019, the company operates from its headquarters in Dallas, Texas.
Aandeelprijs
$6.02
Laatst gesynchroniseerd: 2026-08-27
Marktkapitalisatie
$1.93B
Verandering (1 dag)
0.00%
Verandering (1 jaar)
112.72%
Land
US
Handel Taysha Gene Therapies, Inc. (TSHA)

Categorie

Healthcare
Aandelsplitsingen voor Taysha Gene Therapies, Inc. (TSHA)
Het aandeel Taysha Gene Therapies, Inc. (symbool: TSHA) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Aug 28, 2026.
Eén aandeel TSHA dat vóór Aug 28, 2026 werd gekocht, staat nu gelijk aan 0 aandelen TSHA.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH